We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
42 hedge funds and large institutions have $18.1M invested in Corvus Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
46% more capital invested
Capital invested by funds: $12.4M → $18.1M (+$5.73M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.57% less ownership
Funds ownership: 47.47% → 45.9% (-1.6%)
13% less funds holding
Funds holding: 48 → 42 (-6)
26% less call options, than puts
Call options by funds: $23K | Put options by funds: $31K
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Holders
42
Holders Change
-6
Holders Change %
-12.5%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
14
Closed
11
Calls
$23K
Puts
$31K
Net Calls
-$8K
Net Calls Change
-$18K
Top Buyers
| 1 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
+$486K |
| 2 |
Morgan Stanley
New York
|
+$29.5K |
| 3 |
CB
Commerce Bank
Kansas City,
Missouri
|
+$17.7K |
| 4 |
VF
Virtu Financial
New York
|
+$16.6K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$8.36K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$324K |
| 2 |
Renaissance Technologies
New York
|
-$289K |
| 3 |
Two Sigma Advisers
New York
|
-$195K |
| 4 |
Two Sigma Investments
New York
|
-$131K |
| 5 |
TI
Telemetry Investments
New York
|
-$117K |
